The New York Times reports:
Vaccine manufacturers have been steadily increasing their output, and states have snapped up new doses as quickly as the government could deliver them. But officials expect the supply of vaccines to outstrip U.S. demand by mid-May, if not sooner, and are grappling with what to do with looming surpluses when scarcity turns to glut.
President Biden has promised enough doses by the end of May to immunize all of the nation’s roughly 260 million adults. But between then and the end of July, the government has locked in commitments from manufacturers for enough vaccine to cover 400 million people — about 70 million more than the nation’s entire population.
Read the full article. Ten countries, including the US, have taken around 75% of doses produced so far. Biden may have to decide where the excess goes.
We will soon go from having a “supply problem” to having a “demand problem” with #Covidvaccines in the US while the rest of the world continues to have a critical supply issue. via @NYTimes https://t.co/8JJ0visGck
— Carlos del Rio (@CarlosdelRio7) March 27, 2021